 Centogene N.V. CNTG, a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today announced that the U.S. Food and Drug Administration FDA has issued Emergency Use Authorization EUA for the companys SARS-CoV-2 RT-PCR test. CENTOGENE is proud to have received this accelerated authorization from the FDA, which recognizes our continued commitment to the highest quality standards amid this global pandemic, said Ellen Karges, SVP Regulatory Compliance Quality Management. 